IP Library Patent Application 17799249
Patent Application
App. No. 17/799,249

LOW TOXICITY NMP SUBSTITUTES AND USES THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/799,249
Abstract

The present technology is directed to compounds Formulas I, II, III, and IV as well as compositions that include one or more of the compounds and methods of making the compounds. In particular, the present compounds may be used as a replacement for NMP in compositions to produce lower toxicity compositions.

Claims (78)

1 . A compound of Formula I, Formula II, Formula III, or Formula IV:

wherein:

X is O or CR 33 R 34 ;

R 1 , R 8 , R 9 , R 17 , and R 26 are each independently —CH 3 , —CH 2 CH 3 , —CH 2 CH 2 CH 3 , or —CH(CH 3 ) 2 ;

R 2 , R 3 , R 10 , R 11 , R 14 , and R 15 are each independently —H, —CH 3 , or —CH 2 CH 3 ;

R 6 and R 7 are each independently absent, —H, —CH 3 , —CH 2 CH 3 , —CN, —C(O)N(CH 3 ) 2 , —CH 2 C(O)N(CH 3 ) 2 , —C(O)N(CH 2 CH 3 ) 2 , —CH 2 C(O)N(CH 2 CH 3 ) 2 , —CO 2 CH 3 , or —CH 2 CO 2 CH 3 ;

R 16 is —O—C 1 -C 8 alkyl, —O—C 2 -C 8 (hetero)cycloalkyl, —O—C 4 -C 12 (hetero)aryl, —NH 2 , —NH—C 1 -C 8 alkyl, —N(C 1 -C 8 alkyl) 2 ,

R 18 and R 19 are each independently —H or —C 1 -C 8 alkyl;

R 22 and R 23 are each independently absent, —H or —C 1 -C 8 alkyl;

R 24 and R 25 are each independently —H, —CN, —C 1 -C 8 alkyl, —C 2 -C 8 (hetero)cycloalkyl, —CH 2 —O—C 1 -C 8 alkyl, —C(O)—C 1 -C 8 alkyl, —C 1 -C 8 alkylene-C(O)—C 1 -C 8 alkyl, —C(O)—C 2 -C 8 (hetero)cycloalkyl, —C 1 -C 8 alkylene-C(O)—C 2 -C 8 (hetero)cycloalkyl, —CO 2 H, —CO 2 —C 1 -C 8 alkyl, —C 1 -C 8 alkylene-CO 2 —C 1 -C 8 alkyl, —CO 2 —C 2 -C 8 (hetero)cycloalkyl, —C 1 -C 8 alkylene-CO 2 —C 2 -C 8 (hetero)cycloalkyl, —C 1 -C 8 alkylene-NH 2 , —C 1 -C 8 alkylene-NH—C 1 -C 8 alkyl, —C 1 -C 8 alkylene-N(C 1 -C 8 alkyl) 2 , —C(O)NH 2 , —C 1 -C 8 alkylene-C(O)NH 2 , —C(O)NH—C 1 -C 8 alkyl, —C(O)N(C 1 -C 8 alkyl) 2 , —C 1 -C 8 alkylene-C(O)NH—C 1 -C 8 alkyl, —C 1 -C 8 alkylene-C(O)N(C 1 -C 8 alkyl) 2 , -(hetero)aryl, -(hetero)cycloalkyl,

R 4 , R 5 , R 12 , R 13 , R 20 , R 21 , R 31 , R 32 , R 33 , and R 34 are each independently —H, —CN, —C 1 -C 8 alkyl, —C 2 -C 8 (hetero)cycloalkyl, —O—C 1 -C 8 alkyl, —CH 2 —O—C 1 -C 8 alkyl, —C(O)—C 1 -C 8 alkyl, —C 1 -C 8 alkylene-C(O)—C 1 -C 8 alkyl, —C(O)—C 3 -C 8 cycloalkyl, —C 1 -C 8 alkylene-C(O)—C 2 -C 8 (hetero)cycloalkyl, —CO 2 H, —CO 2 —C 1 -C 8 alkyl, —C 1 -C 8 alkylene-CO 2 —C 1 -C 8 alkyl, —CO 2 —C 2 -C 8 (hetero)cycloalkyl, —C 1 -C 8 alkylene-CO 2 —C 2 -C 8 (hetero)cycloalkyl, —NH 2 , —C 1 -C 8 alkylene-NH 2 , —NH—C 1 -C 8 alkyl, —N(C 1 -C 8 alkyl) 2 , —C 1 -C 8 alkylene-NH—C 1 -C 8 alkyl, —C 1 -C 8 alkylene-N(C 1 -C 8 alkyl) 2 , —C(O)NH 2 , —C 1 -C 8 alkylene-C(O)NH 2 , —C(O)NH—C 1 -C 8 alkyl, —C(O)N(C 1 -C 8 alkyl) 2 , —C 1 -C 8 alkylene-C(O)NH—C 1 -C 8 alkyl, —C 1 -C 8 alkylene-C(O)N(C 1 -C 8 alkyl) 2 , -(hetero)aryl, -(hetero)cycloalkyl,

R 27 and R 28 are each independently —H or —Z—NR 35 R 36 ,

wherein:

Z is a C 1 -C 8 alkylene; and

R 35 and R 36 are each independently —H, —C 1 -C 8 alkyl, -(hetero)aryl, -(hetero)cycloalkyl, —C 1 -C 8 alkylene-OH, —C 1 -C 8 alkylene-NH 2 , —C 1 -C 8 alkylene-NH—C 1 -C 8 alkyl, or —C 1 -C 8 alkylene-N—(C 1 -C 8 alkyl) 2 ;

R 29 and R 30 are each independently absent, —H, —CH 3 , or —CH 2 CH 3 ; and

m, n, and p are each independently 0 or 1.

2 . The compound of claim 1 , wherein R 6 , R 7 , R 22 , R 23 , R 29 , and R 30 are each absent and m, n, and p are each 0.

3 . The compound of any one of claims 1 - 34 , wherein m, n, and p are each 1.

4 . The compound of claim 3 , wherein R 6 is —H, —CH 3 , or —CH 2 CH 3 .

5 . The compound of claim 3 , wherein R 6 is —CN, —C(O)N(CH 3 ) 2 , —CH 2 C(O)N(CH 3 ) 2 , —CO 2 CH 3 , or —CH 2 CO 2 CH 3 .

6 . The compound of any one of claims 3 - 5 , wherein R 7 is —H, —CH 3 , or —CH 2 CH 3 .

7 . The compound of any one of claims 3 - 5 , wherein R 7 is —CN, —C(O)N(CH 3 ) 2 , —CH 2 C(O)N(CH 3 ) 2 , —CO 2 CH 3 , or —CH 2 CO 2 CH 3 .

8 . The compound of any one of claims 3 - 7 , wherein R 22 , R 23 , R 29 , and R 30 is —H, —CH 3 , or —CH 2 CH 3 .

9 . The compound of any one of claims 1 - 8 , wherein R 4 , R 5 , R 12 , R 13 , R 20 , R 21 , R 31 , R 32 , R 33 , and R 34 are each independently —H, —CN, —CH 3 , —CH 2 CH 3 , —OCH 3 , —OCH 2 CH 3 , —C(O)CH 3 , —C(O)CH 2 CH 3 , —CH 2 C(O)CH 3 , —CH 2 COCH 2 CH 3 , —C(O) 2 H, —CO 2 CH 3 , —CO 2 CH 2 CH 3 , —CH 2 CO 2 CH 3 , —CH 2 CO 2 CH 2 CH 3 , —NH 2 , —CH(CH 3 )NH 2 , —CH 2 CH(CH 3 )NH 2 , —CH(CH 3 )CH 2 NH 2 , —C(CH 3 ) 2 NH 2 , —CH 2 C(CH 3 ) 2 NH 2 , —C(CH 3 ) 2 CH 2 NH 2 , —CH 2 NH 2 , —CH 2 CH 2 NH 2 , —CH 2 CH 2 CH 2 NH 2 , —N(CH 3 ) 2 , —N(CH 2 CH 3 ) 2 , —CH 2 N(CH 3 ) 2 , —CH 2 N(CH 2 CH 3 ) 2 , —C(O)N(CH 3 ) 2 , —C(O)N(CH 2 CH 3 ) 2 , —CH 2 C(O)NH 2 , —CH 2 C(O)N(CH 3 ) 2 , —CH 2 C(O)N(CH 2 CH 3 ) 2 , C 4 -C 12 (hetero)aryl, C 2 -C 8 (hetero)cycloalkyl,

10 . The compound of any one of claims 1 - 9 , wherein R 4 , R 5 , R 33 , and R 34 are each independently —H, —CN, —CH 3 , —CH 2 CH 3 , —C(O)CH 3 , —C(O)CH 2 CH 3 , —CH 2 C(O)CH 3 , —CH 2 COCH 2 CH 3 , —CO 2 H, —CO 2 CH 3 , —CO 2 CH 2 CH 3 , —CH 2 CO 2 CH 3 , —CH 2 CO 2 CH 2 CH 3 , —C(O)N(CH 3 ) 2 , —C(O)N(CH 2 CH 3 ) 2 , —CH 2 C(O)NH 2 , —CH 2 C(O)N(CH 3 ) 2 , —CH 2 C(O)N(CH 2 CH 3 ) 2 ,

11 . The compound of any one of claims 1 - 10 , wherein R 4 , R 5 , R 33 , and R 34 are each independently —H, —CN, —CH 3 , —CH 2 CH 3 , —C(O)CH 3 , —CH 2 C(O)CH 3 , —CO 2 H, —CO 2 CH 3 , —CH 2 CO 2 CH 3 , or —C(O)N(CH 3 ) 2 .

12 . The compound of any one of claims 1 - 11 , wherein X is CR 33 R 34 and at least one of R 4 , R 5 , R 33 , and R 34 is not H.

13 . The compound of claim 12 , wherein R 4 is —H and least one of R 5 , R 33 , and R 34 is not —H or R 4 , R 5 , R 33 , and R 34 are each —H and at least one of R 6 and R 7 is not —H.

14 . The compound of any one of claims 1 - 11 , wherein X is O.

15 . The compound of any one of claims 1 - 9 , wherein R 12 is —H; R 13 is —H, —CH 3 , —CH 2 CH 3 , —CN, —C(O)N(CH 3 ) 2 , —CH 2 C(O)N(CH 3 ) 2 , —C(O)N(CH 2 CH 3 ) 2 , —CH 2 C(O)N(CH 2 CH 3 ) 2 , —CO 2 CH 3 , or —CH 2 CO 2 CH 3 ; and R 16 is —OCH 3 , —N(CH 3 ) 2 , or

16 . The compound of any one of claims 1 - 9 , wherein

R 18 and R 19 are each independently —H or —C 1 -C 6 alkyl;

R 20 and R 21 are each independently —H, —CN, —CH 3 , —CH 2 CH 3 , —C(O)CH 3 , —C(O)CH 2 CH 3 , —CH 2 C(O)CH 3 , —CH 2 COCH 2 CH 3 , —C(O) 2 H, —CO 2 CH 3 , —CO 2 CH 2 CH 3 , —CH 2 CO 2 CH 3 , —CH 2 CO 2 CH 2 CH 3 , —C(O)N(CH 3 ) 2 , —C(O)N(CH 2 CH 3 ) 2 , —CH 2 C(O)NH 2 , —CH 2 C(O)N(CH 3 ) 2 , —CH 2 C(O)N(CH 2 CH 3 ) 2 , —C 4 -C 12 (hetero)aryl, —C 2 -C 8 (hetero)cycloalkyl,

R 24 and R 25 are each independently —H, —CN, —C 1 -C 4 alkyl, —C 2 -C 6 (hetero)cycloalkyl, —CH 2 —O—C 1 -C 4 alkyl, —C(O)—C 1 -C 4 alkyl, —C 1 -C 4 alkylene-C(O)—C 1 -C 4 alkyl, —C(O)—C 2 -C 6 (hetero)cycloalkyl, —C 1 -C 4 alkylene-C(O)—C 2 -C 6 (hetero)cycloalkyl, —CO 2 H, —CO 2 —C 1 -C 4 alkyl, —C 1 -C 4 alkylene-CO 2 —C 1 -C 4 alkyl, —CO 2 —C 2 -C 6 (hetero)cycloalkyl, —C 1 -C 4 alkylene-CO 2 —C 2 -C 6 (hetero)cycloalkyl, —C 1 -C 4 alkylene-NH 2 , —C 1 -C 4 alkylene-NH—C 1 -C 4 alkyl, —C 1 -C 4 alkylene-N(C 1 -C 4 alkyl) 2 , —C(O)NH 2 , —C 1 -C 4 alkylene-C(O)NH 2 , —C(O)NH—C 1 -C 4 alkyl, —C(O)N(C 1 -C 4 alkyl) 2 , —C 1 -C 4 alkylene-C(O)NH—C 1 -C 4 alkyl, —C 1 -C 4 alkylene-C(O)N(C 1 -C 4 alkyl) 2 , —C 4 -C 12 (hetero)aryl, or —C 3 -C 6 (hetero)cycloalkyl.

17 . The compound of any one of claims 1 - 9 or 16 , wherein R 21 is —H, —CH 3 , —CH 2 CH 3 , —CO 2 CH 3 , or phenyl; n is 0; and R 22 and R 23 are absent.

18 . The compound of any one of claims 1 - 9 , 16 , or 17 , wherein R 24 is —H, —CN, —C(O)CH 3 , —CO 2 CH 3 , —CH 2 CO 2 CH 3 , —C(O)N(CH 3 ) 2 , phenyl, cyclopentyl, or cyclohexyl and R 25 is —CN, —C(O)CH 3 , —CO 2 CH 3 , —CH 2 CO 2 CH 3 , —C(O)N(CH 3 ) 2 , phenyl, cyclopentyl, or cyclohexyl.

19 . The compound of any one of claims 1 - 9 , wherein R 28 is —Z—NR 35 R 36 , wherein R 35 and R 36 are each independently —H or —C 1 -C 2 alkyl.

20 . The compound of any one of claims 1 - 19 , wherein the compound has a boiling point above about 225° C.

21 . The compound of any one of claims 1 - 20 , wherein the compound has a longer gas chromatography retention time than diethyl adipate, hexadecane, methyl palmitate, or a combination of two or more thereof.

22 . The compound of any one of claims 1 - 21 , wherein the compound is low VOC.

23 . The compound of any one of claims 1 - 22 , wherein the compound has a toxicity lower than N-methyl-2-pyrrolidione.

24 . A composition comprising the compound of Formula I, Formula II, Formula III, Formula IV, or a combination thereof in any one of claims 1 - 23 .

25 . The composition of claim 24 , wherein the composition is substantially free of N-methyl-2-pyrrolidione (NMP).

26 . The composition of claim 24 or claim 25 , wherein the composition is a known composition to contain NMP and the compound replaces the NMP in the composition.

27 . The composition of any one of claims 24 - 26 , wherein the composition is a paint or coating, stripper (e.g., paint, photoresist, furniture, graffiti, wheel, nail polish remover), cleaner (e.g., oven, surface, floor, automotive, industrial, optic, printed circuit board, or semiconductor), adhesive/binder/sealant, leather treatment, personal care (i.e., commonly used as a surfactant), screen printing (e.g., lithographic, silk), pharmaceutical formulation, and/or manufacturing (e.g., electronic such as printed circuit board, defluxing, or semiconductor; pharmaceutical; agrochemical; petrochemicals; plasticizer; ink).

28 . A method of making the compound of Formula I in any one of claims 1 - 23 comprising:

reacting a nitroalkane and an acrylate reagent to form a nitro alkanoyl reagent;

optionally derivatizing the nitro alkanoyl reagent;

reducing the nitro acrylate reagent to form an amino alkanoyl reagent;

optionally derivatizing the amino alkanoyl reagent;

cyclizing the amino alkanoyl reagent to form a compound of Formula Ia:

and

alkylating the compound of Formula Ia;

wherein R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 33 , R 34 , and m are as defined in any one of claims 1 - 23 .

29 . A method of making the compound of Formula I in any one of claims 1 - 23 comprising:

reacting a nitroalkane and a ketone or aldehyde to form a nitroalcohol;

optionally derivatizing the nitroalcohol;

reducing the nitroalcohol to form an aminoalcohol;

optionally derivatizing the aminoalcohol; and

cyclizing the aminoalcohol in the presence of carbon dioxide to form a compound of Formula Id:

and

alkylating the compound of Formula Id;

wherein R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and m are as defined in any one of claims 1 - 23 .

30 . A method of making the compound of Formula II in any one of claims 1 - 23 comprising:

reacting a nitroalkane and an acrylate reagent to form a nitro alkanoyl reagent;

optionally derivatizing the nitro alkanoyl reagent;

reducing the nitro alkanoyl reagent to form a compound of Formula IIa:

and

alkylating the compound of Formula IIa;

wherein R 10 , R 11 , R 12 , R 13 , R 14 , R 14 , and R 16 are as defined in any one of claims 1 - 23 .

31 . A method of making the compound of Formula III in any one of claims 1 - 23 comprising:

reducing a nitroalkane to form an alkylhydroxylamine;

reacting the alkylhydroxylamine and an aldehyde to form a nitrone; and

reacting the nitrone and an alkene.

32 . A method of making the compound of Formula IV in any one of claims 1 - 23 comprising:

reacting a nitroalkane and a maleimide to form a nitropyrrolidine-dione; and

reducing the nitropyrrolidine-dione to form the compound of Formula IV.

Assignments (4)
CHANGE OF NAME Recorded Sep 14, 2023
From: ANGUS CHEMICAL COMPANY
To: ADVANCION CORPORATION
Reel/Frame 064913/0129 →
PATENT SECURITY AGREEMENT (1ST LIEN) Recorded Aug 25, 2023
From: ANGUS CHEMICAL COMPANY
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064717/0555 →
PATENT SECURITY AGREEMENT (2ND LIEN) Recorded Aug 25, 2023
From: ANGUS CHEMICAL COMPANY
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 064717/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 11, 2022
From: GREEN, G. DAVID; QUINN, JORDAN
To: ANGUS CHEMICAL COMPANY
Reel/Frame 060789/0608 →